Chemo with your own stem cells for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at giving chemotherapy with an added support step using your own collected stem cells. It may help people with recurrent or metastatic ovarian cancer by supporting bone marrow recovery while treatment continues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 60 years old
- Have ovarian cancer that has been confirmed by tissue biopsy (histopathology) and is recurrent or metastatic
- Your cancer doctor says you need chemotherapy for ovarian cancer
- Be able to do everyday activities fairly well (ECOG 0–1) and expect to live more than 3 months
- If you can become pregnant, have a negative pregnancy test and use reliable birth control during treatment and for 6 months after
- Have healthy enough bone marrow to collect and mobilize (release) your stem cells for collection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental therapy called SCT-001 CAR T cells, made from your own immune cells, for ovarian cancer that has not responded to standard treatments. The goal is to see if these engineered cells can find and attack your cancer cells, which could help shrink or control the disease.
This Phase 1 study tests whether giving your own immune cells—engineered to target the FSH receptor—can control recurrent ovarian-related cancers. It’s mainly looking at safety and early signs of activity for patients whose cancer has not responded well to standard platinum chemotherapy.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight ovarian cancer that has returned. After collecting and growing these cells, you receive chemotherapy and other drugs to help them work better.
This trial tests a personalized cancer vaccine made from your own tumor cells. It is for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has returned after at least one round of platinum chemotherapy.
This trial tests a different way of giving chemotherapy to people with advanced ovarian cancer that didn't respond well to initial treatment. The goal is to see if changing the dose and schedule can improve outcomes.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.